Diana PignalosaHead of Strategic Partnering at Debiopharm International SASpeaker
Profile
Dr. Diana Pignalosa is a distinguished scientist-executive whose career seamlessly integrates deep scientific expertise with high-impact leadership in the global biopharmaceutical industry. Dr. Pignalosa has meticulously constructed a career that bridges the worlds of fundamental academic research and strategic corporate development.
Dr. Pignalosa's expertise spans advanced radiobiology, hemato-oncology, and DNA engineering, with significant contributions to understanding the effects of ionizing radiation on cells. Her transition to the pharmaceutical industry involved strategic roles at Kyorin Europe GmbH and IQVIA, where she honed her skills in business development and strategic consulting. At Debiopharm, she leads the team responsible for scouting new opportunities and managing partnerships, leveraging her scientific acumen to identify and evaluate promising new drugs.
Engaging with Dr. Pignalosa for partnering discussions offers a unique advantage. Her dual expertise in science and business, combined with her strategic vision and global network, makes her an invaluable partner in driving innovation and securing high-potential assets in the biopharmaceutical sector.
Agenda Sessions
Market Briefing: Inside China’s biopharma ensemble
, 13:30View Session